---
title: "GuoTong: Net loss of 31.5259 million yuan in the first quarter of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238055106.md"
description: "GuoTong announced that in the first quarter of 2025, the operating revenue was 27.206 million yuan, a year-on-year decrease of 48.75%. The net loss was 31.5259 million yuan, compared to a net loss of 20.8568 million yuan in the same period last year"
datetime: "2025-04-29T12:22:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238055106.md)
  - [en](https://longbridge.com/en/news/238055106.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238055106.md)
---

# GuoTong: Net loss of 31.5259 million yuan in the first quarter of 2025

GuoTong announced that in the first quarter of 2025, operating revenue was 27.206 million yuan, a year-on-year decrease of 48.75%. The net loss was 31.526 million yuan, compared to a net loss of 20.857 million yuan in the same period last year

### Related Stocks

- [002205.CN](https://longbridge.com/en/quote/002205.CN.md)

## Related News & Research

- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Correction of a Managers' transactions announcement according to article 19 MAR from 19.05.2026](https://longbridge.com/en/news/287058272.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md)
- [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)